DUBLIN, Jan. 5, 2022 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that its Chief Executive Officer,
Richard Pops, will provide a
corporate overview and update at the 40th Annual J.P.
Morgan Healthcare Conference. The presentation will take place
virtually on Wednesday, Jan. 12, 2022
at 11:15 a.m. EST (4:15 p.m. GMT), followed by a question and answer
session. The live webcast may be accessed under the Investors tab
on www.alkermes.com and will be archived for 14 days.
About Alkermes plc
Alkermes plc is a
fully-integrated, global biopharmaceutical company developing
innovative medicines in the fields of neuroscience and oncology.
The company has a portfolio of proprietary commercial products
focused on addiction, schizophrenia and bipolar I disorder, and a
pipeline of product candidates in development for neurodegenerative
disorders and cancer. Headquartered in Dublin,
Ireland, Alkermes plc has an R&D center
in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility
in Wilmington, Ohio. For more information, please visit
Alkermes' website at www.alkermes.com.
Contact:
Alex Braun
Investor Relations
+1 781 296 8493
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alkermes-to-take-part-in-the-40th-annual-jp-morgan-healthcare-conference-301454212.html
SOURCE Alkermes plc